Richard Thomas Williams

Insider Reports History

Entity
Individual
Location
C/O Kinnate Biopharma Inc., 11975 El Camino Real, Suite 101, San Diego, CA
Signature
/s/ Mark A. Meltz, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Thomas Williams:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kinnate Biopharma Inc. CHIEF MEDICAL OFFICER Common Stock 67.6K $175K $2.59 Mar 1, 2024 Direct

Insider Reports Filed by Richard Thomas Williams

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KNTE Kinnate Biopharma Inc. Mar 1, 2024 1 -$1.45K 4 Mar 5, 2024 CHIEF MEDICAL OFFICER
KNTE Kinnate Biopharma Inc. Dec 1, 2023 1 -$1.22K 4 Dec 5, 2023 Chief Medical Officer
KNTE Kinnate Biopharma Inc. Sep 1, 2023 1 -$1.27K 4 Sep 6, 2023 Chief Medical Officer
KNTE Kinnate Biopharma Inc. Jun 1, 2023 1 -$2.33K 4 Jun 5, 2023 Chief Medical Officer
KNTE Kinnate Biopharma Inc. Mar 1, 2023 1 -$3.32K 4 Mar 3, 2023 Chief Medical Officer
KNTE Kinnate Biopharma Inc. Feb 10, 2023 1 $0 4 Feb 14, 2023 Chief Medical Officer
KNTE Kinnate Biopharma Inc. Dec 1, 2022 1 -$4.19K 4 Dec 2, 2022 Chief Medical Officer
KNTE Kinnate Biopharma Inc. Sep 1, 2022 1 $0 4 Sep 2, 2022 Chief Medical Officer
KNTE Kinnate Biopharma Inc. Mar 11, 2022 2 $339K 4 Mar 15, 2022 Chief Medical Officer
KNTE Kinnate Biopharma Inc. Feb 11, 2022 1 $0 4 Feb 15, 2022 Chief Medical Officer